Pages that link to "Q37557487"
Jump to navigation
Jump to search
The following pages link to CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. (Q37557487):
Displayed 43 items.
- Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1 (Q24296240) (← links)
- CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells (Q24529963) (← links)
- The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis (Q26795473) (← links)
- DPP4 in Diabetes (Q26797335) (← links)
- Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials (Q28081569) (← links)
- Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7 (Q28257757) (← links)
- Increased phosphorylation of caveolin-1 in the spinal cord of irradiated rats (Q28580901) (← links)
- Exploiting the full power of temporal gene expression profiling through a new statistical test: application to the analysis of muscular dystrophy data (Q31035733) (← links)
- Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma (Q33555260) (← links)
- Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice (Q34718822) (← links)
- Clinical significance of soluble CD26 in malignant pleural mesothelioma (Q34744092) (← links)
- Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes (Q34785386) (← links)
- CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion (Q35030407) (← links)
- Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice (Q35288471) (← links)
- Role of caveolin-3 in lymphocyte activation. (Q35541260) (← links)
- Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset (Q35837580) (← links)
- Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes (Q36056986) (← links)
- T-cell activation via CD26 and caveolin-1 in rheumatoid synovium (Q36452687) (← links)
- A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation (Q36477217) (← links)
- Dipeptidyl peptidase-4: a key player in chronic liver disease (Q36783164) (← links)
- Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells (Q37123548) (← links)
- CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells (Q37510305) (← links)
- The dipeptidyl peptidase IV family in cancer and cell biology. (Q37674999) (← links)
- Caveolin-1: a critical regulator of lung injury (Q37811611) (← links)
- Recent patents of dipeptidyl peptidase IV inhibitors (Q37948110) (← links)
- Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors (Q38248682) (← links)
- DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. (Q38413395) (← links)
- Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function (Q38542686) (← links)
- Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress. (Q38657340) (← links)
- DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis (Q38732531) (← links)
- The expression of proline-specific enzymes in the human lung (Q38809929) (← links)
- DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation (Q38870486) (← links)
- CD26 and Asthma: a Comprehensive Review. (Q38937243) (← links)
- Integrated inference and evaluation of host-fungi interaction networks (Q38971569) (← links)
- Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. (Q39103371) (← links)
- Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: a matter of dose, route, and time (Q41866098) (← links)
- CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production (Q44561307) (← links)
- Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines (Q45721715) (← links)
- CD26: a negative selection marker for human Treg cells (Q46762458) (← links)
- Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review (Q58579298) (← links)
- Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes (Q64266446) (← links)
- Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways (Q64286922) (← links)
- CD26 T cells in the pathogenesis of asthma (Q81162725) (← links)